Welcome to the BioLogicTube jeo@biologicmedia.dk https://biologictube.dk/app/facebook en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Welcome to the BioLogicTube episodic no https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif https://biologictube.dk/app/facebook http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes <p>Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)</p><p><a href="http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes"><img src="http://biologictube.dk/49543318/53580443/a34f811ef3ad7f14e2072b914382ec3a/standard/download-2-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/53580443 Wed, 03 Jul 2019 12:53:40 GMT Prof. Peter Rossing on diabetes complications Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long) Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter... Welcome to the BioLogicTube 05:34 <p>Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)</p><p><a href="http://biologictube.dk/photo/53580443/prof-peter-rossing-on-diabetes"><img src="http://biologictube.dk/49543318/53580443/a34f811ef3ad7f14e2072b914382ec3a/standard/download-2-thumbnail.jpg" width="600" height="338"/></a></p> cardiovascular complications early intervention early prediction End-stage renal disease ESRD Jesper Eugen-Olsen Jørgen Jeppesen late stage complications Persson F risk prediction Simone Theilade soluble urokinase plasminogen activator receptor suPAR Tine W. Hansen Tofte N Type 1 diabetes Viktor Curovic Winther SA http://biologictube.dk/photo/19927485/routine-use-of-suparnostic-in-the-emergency <p>At Copenhagen University Hospital Hvidovre, suPAR is measured as part of the routine biomarkers. suPAR is used as support for the decision to admit or discharge the acute medical patient. For more info on the suPARnostic products, please go to Virogates.com<br></p><p><a href="http://biologictube.dk/photo/19927485/routine-use-of-suparnostic-in-the-emergency"><img src="http://biologictube.dk/19476794/19927485/19fd3c12c66fb2424c10772a1b61b799/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/19927485 Wed, 15 Nov 2017 14:48:58 GMT Routine use of suPARnostic in the Emergency Department At Copenhagen University Hospital Hvidovre, suPAR is measured as part of the routine biomarkers. suPAR is used as support for the decision to admit or discharge the acute medical patient. For more info on the suPARnostic products, please go to Virogates.com At Copenhagen University Hospital Hvidovre, suPAR is measured as part of the routine biomarkers. suPAR is used as support for the decision to admit or discharge the acute medical patient. For more info on the suPARnostic products, please go to... Welcome to the BioLogicTube 01:14 <p>At Copenhagen University Hospital Hvidovre, suPAR is measured as part of the routine biomarkers. suPAR is used as support for the decision to admit or discharge the acute medical patient. For more info on the suPARnostic products, please go to Virogates.com<br></p><p><a href="http://biologictube.dk/photo/19927485/routine-use-of-suparnostic-in-the-emergency"><img src="http://biologictube.dk/19476794/19927485/19fd3c12c66fb2424c10772a1b61b799/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> admit or discharge biomarker inflammation prognosis risk prediction routine biomarker support for your clinical decision unspecific http://biologictube.dk/photo/9922086/dr-rafal-wlazel-talks-on-supar-and <p>The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wlazel's presentation was one of 25 lectures gicen over the 2-day Internationl suPAR&nbsp;symposium</p><p><a href="http://biologictube.dk/photo/9922086/dr-rafal-wlazel-talks-on-supar-and"><img src="http://biologictube.dk/9826383/9922086/516962cb20d5459ef9d59ccacaa692cc/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/9922086 Fri, 13 Jun 2014 11:41:26 GMT Dr. Rafal Wlazel talks on suPAR and prediction of AMI in pPCI patients The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wlazel's presentation was one of 25 lectures gicen over the 2-day Internationl suPARsymposium The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus... Welcome to the BioLogicTube 09:09 <p>The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wlazel's presentation was one of 25 lectures gicen over the 2-day Internationl suPAR&nbsp;symposium</p><p><a href="http://biologictube.dk/photo/9922086/dr-rafal-wlazel-talks-on-supar-and"><img src="http://biologictube.dk/9826383/9922086/516962cb20d5459ef9d59ccacaa692cc/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> acute care biomarker biomarker triage cardiac eugen-olsen frank tacke helle fisker hvidovre hosptal inflammation jakob knudsen markus schultz medical triage nstemi pci poland prediction prognostic risk risk prediction risk stratification soluble urokinase plasminogen activator receptor stemi supar triage virogates